Patents for C07D 285 - Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups (9,964) |
---|
08/12/2008 | US7411095 obtained using specific secondary amines are unexpectedly stable against water; reacting an aldehyde or ketone with an amine and treating the resulting reaction mixture with an acidic aqueous solution |
08/12/2008 | US7410964 Cyclohexyl sulphones as gamma-secretase inhibitors |
08/07/2008 | WO2008093674A1 Novel thiadiazole derivative having kinase inhibitory activity |
08/07/2008 | US20080188490 e.g. 1-(3-Chloro-phenylethynyl)-3-(3,4-difluoro-phenylamino)-cyclohexanol; metabotropic glutamate receptors modulator/antagonist; |
08/07/2008 | US20080188460 Tricyclic compounds, a process for their preparation and pharmaceutical compositions containing them |
08/07/2008 | US20080188455 angiogenesis and/or cell proliferation, carcinoma, myeloid leukemia, endometriosis; inhibitors of the receptor protein tyrosine kinase; N3-(3-cyclopentyl-1,2,3,4,5,6-hexahydrobenzo[d]azocin-8-yl)-1-(6-fluoroquinazolin-4-yl)-1H-1,2,4-triazole-3,5-diamine |
08/07/2008 | US20080187978 Anti-inflammatory medicaments |
08/06/2008 | EP1951719A2 Certain chemical entities, compositions, and methods |
08/06/2008 | EP1951697A1 Substituted 5-phenyl-3,6-dihydro-2-oxo-6h-[1,3,4]thiadiazines |
08/06/2008 | EP1439169B1 Difluoroalkene derivative, pest control agent containing the same, and intermediate therefor |
08/06/2008 | CN100408625C Thermoplasltic elastomer composition |
08/06/2008 | CN100408567C Benzothiadiazepine derivatives, processes for their preparation and pharmaceutical compositions containing them |
08/05/2008 | US7408068 Compounds for the treatment of neurodegenerative disorders |
08/05/2008 | CA2279319C Benzofurazan compounds which enhance ampa receptor activity |
07/31/2008 | US20080182992 Mitotic Kinesin Inhibitors and Methods of Use Thereof |
07/29/2008 | US7405233 e.g. 3-[3-(4-ISOPROPYLPHENYL)-2,5-DIOXO-IMIDAZOLIDIN-1-YL]-BENZOIC ACID SODIUM SALT; method of modulating premature translation termination and/or nonsense-mediated mRNA decay in a cell in vitro; cystic fibrosis or Duchenne muscular dystrophy |
07/29/2008 | CA2284653C Tetraaza- or n2s2- complexants, and their use in radiodiagnostics or radiotherapy |
07/24/2008 | WO2008073956A3 Cyclic sulfonamide derivatives and methods of their use |
07/24/2008 | WO2008032858A3 Thiadiazole compound and use thereof |
07/24/2008 | US20080176899 Such as 1-Benzo[1,3]dioxol-5-yl-cyclopropanecarboxylic acid [5-(2-methoxy-pyridin-3-ylmethyl)-thiazol-2-yl]-amide 5-(2-Methoxy-pyridin-3-ylmethyl)-thiazol-2-ylamine; cystic fibrosis transmembrane conductance regulator disorders |
07/24/2008 | US20080176830 Compounds, Compositions, and Methods |
07/17/2008 | WO2008084872A1 Hydrazone derivative |
07/17/2008 | US20080171737 Cyclic sulfonamide derivatives and methods of their use |
07/16/2008 | EP1574505B1 1,2,4-thiadiazole compounds and use thereof |
07/16/2008 | CN100402512C Benzo[1,2,5]oxadiazoles and benzo [1,2,5]thiadiazoles useful as histopathological staining agents, imaging agents and biomarkers |
07/15/2008 | US7399765 Substituted diazabicycloalkane derivatives |
07/15/2008 | CA2441836C New diaminedithiol derivatives and radiorhenium or radiotechnetium complex thereof; a liver cancer-treating composition comprising the radiorhenium complex and lipiodol; and a kitfor preparation of the liver cancer-treating composition |
07/10/2008 | WO2008036652A3 Amidines as modulators of indoleamine 2,3-dioxygenase |
07/10/2008 | US20080167353 To treat viral infections and tumors; hepadnaviruses, flaviviruses, herpesviruses and human immunodeficiency virus; treating 3TC (L(-)SddC) resistant hepatitis B virus infections; 9-benzo[1,3]dioxol-5-yl-8-benzyloxymethyl-naphtho[1,2-d][1,3]dioxole-7-carboxylic acid benzyl ester |
07/10/2008 | US20080167303 Aryl sulfamide derivatives and methods of their use |
07/09/2008 | CN101218237A Oxime derivative and preparations thereof |
07/09/2008 | CN100400523C Substituted piperazines,(1,4) diaszepines, and 2,5-diazabicyclo (2.2.1)iieptanes as histamine h1 and/or h3 antagonists or histamine h3 reverse antagonists |
07/08/2008 | US7396960 Diphenyl(vinyloxyhydrocarbyloxybenzene)sulfonium salts, e.g., p-vinyloxyethoxyphenyldiphenylsulfonium perfluorobutanesulfonate or cyclo(1,3-perfluoropropanedisulfon)imide; acid generating photoinitiators with good photoresist compatability |
07/03/2008 | WO2008078674A1 Glucokinase-activating substance |
07/03/2008 | WO2008077507A1 Heteroaryl-substituted carboxamides and use thereof for the stimulation of the expression of no synthase |
07/03/2008 | US20080161366 Aminoalkyl substituted aryl sulfamide derivatives and methods of their use |
07/03/2008 | US20080161295 e.g. 3-(2,2-dioxido-1-phenyl-1,4-dihydro-3H-2,1,3-benzothiadiazin-3-yl)-N-methylpropan-1-amine; monoamine reuptake inhibitors; antidepressant, anxiolytic, anticarcinogenic, antiinflammatory, antidiabetic agent; hyperactivity, sleep disturbance, social phobia, chronic fatigue syndrome, viral infection |
07/03/2008 | CA2672088A1 Glucokinase activator |
07/02/2008 | EP1939181A1 Heteroaryl-substituted carboxamides and use thereof for the stimulation of the expression of NO synthase |
07/02/2008 | EP1937659A1 Cyclic n-[1 ,3,4]-thiadiazol-2-yl-benzene sulfonamides, processes for their preparation and their use as pharmaceuticals |
07/02/2008 | EP1937658A1 4-oxy-n-[1 ,3,4]-thiadiazol-2-yl-benzene sulfonamides, processes for their preparation and their use as pharmaceuticals |
07/02/2008 | EP1937657A1 N-[1 ,3,4]-thiadiazol-2-yl-benzene sulfonamides, processes for their preparation and their use as pharmaceuticals |
07/02/2008 | CN100399195C Azine-based charge transport materials |
07/02/2008 | CN100398536C Compounds, methods and formulations for the oral delivery of a glucagon like peptide (glp)-1 compound or an melanocortin 4 receptor (mc4) agonist peptide |
06/26/2008 | WO2008077138A1 3-benzofuranyl-4-indolyl maleimides as potent gsk3 inhibitors for neurogenerative disorders |
06/26/2008 | WO2008076754A2 Compounds and compositions as inhibitors of cannabinoid receptor 1 activity |
06/26/2008 | WO2008075026A1 4-hydr0xy-2-0x0-2, 3 -dihydro- 1, 3-benzothiazol- 7yl compounds for modulation of b2-adrenoreceptor activity |
06/26/2008 | WO2008074132A1 Inhibitors of histone deacetylase and prodrugs thereof |
06/26/2008 | US20080153886 4-Benzyl-[1,2,4]thiadiazolidine-3,5-dione or thione derivatives are used to treat nerve damage associated with prion diseases, Creutzfeld-Jakob disease, Gerstmann-Straussler-Scheinker syndrome, muscular dystrophy, diabetic neuropathy, optic nerve injury, glaucoma, depression, bipolar disease, and ADT |
06/26/2008 | US20080153835 Therapeutic agents useful for treating pain |
06/26/2008 | CA2673368A1 3-benzofuranyl-4-indolyl maleimides as potent gsk3 inhibitors for neurogenerative disorders |
06/26/2008 | CA2672811A1 4-hydroxy-2-oxo-2,3-dihydro-1,3-benzothiazol-7yl compounds for modulation of b2-adrenoreceptor activity |
06/26/2008 | CA2672271A1 Compounds and compositions as inhibitors of cannabinoid receptor 1 activity |
06/26/2008 | CA2672192A1 Inhibitors of histone deacetylase and prodrugs thereof |
06/25/2008 | EP1935869A1 Retinoids for the treatment of emphysema |
06/25/2008 | EP1934233A1 Sulfonamide derivatives as glycokinase activators useful in the treatment of type 2 diabetes |
06/25/2008 | EP1934193A1 Benzothiadiazolyphenylalkylamine derivatives for use in the treatment of conditions ameliorated by monoamine reuptake |
06/25/2008 | EP0986382B1 Raf kinase inhibitors |
06/25/2008 | CN101208318A 1,2,4-thiadiazole compound, its use for controlling harmful organism and intermediate thereof |
06/25/2008 | CN101205217A Compound, composite nano particle, grease and production methods thereof |
06/25/2008 | CN100396673C New benzothiadiazine compounds, a process for their preparation and pharmaceutical compositions containing them |
06/24/2008 | US7390908 Such as 2-[3,5-Di(2-chlorobenzyloxy)benzoyl)amino]-thiazole; for treatment of diabetes |
06/19/2008 | WO2008073958A2 Substituted benzothiadiazinedioxide derivatives and methods of their use |
06/19/2008 | WO2008073956A2 Cyclic sulfonamide derivatives and methods of their use |
06/19/2008 | WO2008073459A1 Aryl sulfamide derivatives and methods of their use |
06/19/2008 | WO2008071421A1 Nitrate esters of carbonic anhydrase inhibitors |
06/19/2008 | US20080146625 Oxime glucokinase activators |
06/19/2008 | US20080146624 Amidines as modulators of indoleamine 2,3-dioxygenase |
06/19/2008 | CA2671844A1 Aryl sulfamide derivatives and methods of their use |
06/17/2008 | US7388097 controlling microorganisms; microbiocides; fungicides |
06/17/2008 | CA2286772C Fungicide active substance combinations |
06/12/2008 | US20080139576 5-Substituted 1,1-Dioxo- 1,2,5- Thiadiazolidin-3-One Derivatives |
06/12/2008 | US20080139565 Anthranilic Acid Derivatives and Their Use in Treatment of Diseases of Lipid Metabolism, in Particular Dyslipidaemia |
06/12/2008 | US20080138291 e.g. (4-Sulfamoylphenyl)thioureido fluorescein; bind to the enzyme under hypoxic conditions and are able to reverse the tumor acidification mediated by the enzyme; fluorescent dye for tumor detection by positron-emission tomography; antitumor, antiproliferative agent |
06/12/2008 | US20080134448 vivid color to hair without causing decomposition of the direct azo dye; excellent fastness to light, wash, sweat, friction and heat; stable to alkalizing agents and oxidizing agents; 4-azo-2,1,3-BENZOTHIADIAZOLE dyes |
06/11/2008 | CN100394308C Organophotoreceptor with charge transport material having bis(9-fluorenone) azine groups |
06/11/2008 | CN100393713C Therapeutic agents useful for treating pain |
06/10/2008 | US7385063 Method for preparing imidazole derivatives |
06/10/2008 | US7384967 Aryl carbonyl derivatives as therapeutic agents |
06/10/2008 | CA2280668C An improved process for the conversion of 2-(methylthio)-5-(trifluoromethyl)-1,3,4-thiadiazole (tda) to 2-(methylsulfonyl)-5-(trifluoromethyl)-1,3,4-thiadiazole (tda sulfone) |
06/05/2008 | US20080132551 Positive allosteric modulators of the nicotinic acetylcholine receptor |
06/05/2008 | US20080132511 Sulfonamide compounds |
06/05/2008 | US20080132506 Anti-inflammatory medicaments |
06/04/2008 | EP1926718A1 Pesticide thiazolyloxy substituted phenylamidine derivatives |
06/04/2008 | EP1343775B1 Piperazine derivatives |
06/04/2008 | EP1204643B1 Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation |
06/04/2008 | CN101193878A Agent for treatment of solid tumor |
06/04/2008 | CN101193877A Agent for treatment of hematopoietic tumor |
06/04/2008 | CN100391950C 1,2,4-thiadiazole compounds and use thereof |
05/29/2008 | WO2008061781A1 Thiadiazole derivatives for the treatment of neuro-degenerative diseases |
05/29/2008 | WO2008042928A3 Oxadiazole and thiadiazole derivatives as mitotic kinesin inhibitors and methods of use thereof |
05/29/2008 | US20080125469 Thiadiazole compounds and methods of use thereof |
05/28/2008 | EP1603891B1 New amide derivatives of 2,2,3,3-tetramethylcyclopropane carboxylic acid |
05/28/2008 | CN100390135C Novel derivatives of dicarboxylic acid having pharmaceutical properties |
05/27/2008 | US7378529 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 |
05/27/2008 | US7378448 Diphenylether amide derivatives as opioid receptor antagonists |
05/27/2008 | US7378414 Viricides for infections caused by an RNA-containing virus; enzyme inhibitors for a hepatitis C virus (HCV) polymerase; inhibiting HCV viral replication; liver cirrhosis; e. g., 3-(1,1-dioxido-4H-1,2,4-benzothiadiazin-3-yl)-4-hydroxy-1,1-dipropyl-2(1H)-naphthalenone |
05/27/2008 | CA2272063C Antithrombotic organic nitrates |
05/22/2008 | WO2008059128A1 Phenylic derivatives and use thereof as drugs |
05/22/2008 | WO2008059025A1 Novel 2-(2-hydroxyphenyl) benzothiadiazines useful for treating obesity and diabetes |